Dauch Corporation Common Stock (DCH)
Stock · NYSE · Consumer Discretionary
$4.84as of 10/16/2026
Price chart
Active signals
DCH Signal Track Record
How signals performed across all stocks →What DCH's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 34 | -0.9% | 47% | September 24, 2026 |
| Bollinger Band BreakdownActive now | 22 | +2.5% | 55% | September 24, 2026 |
| 200-Day Moving Average TouchActive now | 22 | -2.4% | 41% | August 26, 2026 |
| Bollinger Band Breakout | 17 | +1.0% | 59% | July 30, 2026 |
| Any 20-session window (baseline) | -0.1% | 49% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About DCH
Dauch Corporation, together with its subsidiaries, designs, engineers, and manufactures driveline and metal forming technologies that supports electric, hybrid, and internal combustion vehicles. It operates through two segments, Driveline and Metal Forming segments. The Driveline segment offers front and rear axles, driveshafts, differential assemblies, clutch modules, balance shaft systems, disconnecting driveline t…
- Sector
- Consumer Discretionary
- Industry
- Auto Parts:O.E.M.
- Employees
- 18,000
- Website
- www.aam.com/investors
Fundamentals
- 1-day range
- $4.78$5.2
- Market cap
- $1.35B
- P/E (trailing)
- —
- P/E (forward)
- 4.40
- EPS (trailing)
- $-1.07
- Dividend yield
- —
- Beta
- 1.77
- Avg. volume
- 3.42M
- Ex-dividend date
- December 4, 2008
How Dauch Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 13, 2026 · via SEC EDGAR / Finnhub
Forecasts
12 analyst ratings
Dauch Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- DCHDauch Corporation Common Stock$4.84▼ 5.10%Market cap $1.35BP/E —$4.92$9.25
- THRMGentherm Inc Common Stock$29.04▼ 2.58%Market cap $1.24BP/E 62.75$27$48.35
- ADNTAdient plc Ordinary Shares$17.94▼ 1.32%Market cap $1.48BP/E 29.24$16.51$27.32
- AEVAAeva Technologies Inc. Common Stock$10.03▼ 8.78%Market cap $1.59BP/E —$8.83$31.3
- APOGApogee Enterprises Inc. Common Stock$41.38▲ 0.29%Market cap $900.05MP/E 12.20$30.75$50.88
- CPSCooper-Standard Holdings Inc. Common Stock$20.83▼ 3.03%Market cap $490.58MP/E —$20.25$47.98
- HLLYHolley Inc. Common Stock$2.49▼ 4.60%Market cap $365.61MP/E 30.38$2.25$4.48
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DCH Dauch Corporation Common Stock | $1.35B | — | $4.84 | ▼ 5.10% | $4.92$9.25 |
| THRM Gentherm Inc Common Stock | $1.24B | 62.75 | $29.04 | ▼ 2.58% | $27$48.35 |
| ADNT Adient plc Ordinary Shares | $1.48B | 29.24 | $17.94 | ▼ 1.32% | $16.51$27.32 |
| AEVA Aeva Technologies Inc. Common Stock | $1.59B | — | $10.03 | ▼ 8.78% | $8.83$31.3 |
| APOG Apogee Enterprises Inc. Common Stock | $900.05M | 12.20 | $41.38 | ▲ 0.29% | $30.75$50.88 |
| CPS Cooper-Standard Holdings Inc. Common Stock | $490.58M | — | $20.83 | ▼ 3.03% | $20.25$47.98 |
| HLLY Holley Inc. Common Stock | $365.61M | 30.38 | $2.49 | ▼ 4.60% | $2.25$4.48 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Dauch Appoints Nathan Iles CFO, Effective Dec. 1, Succeeding Christopher Maybenzinga · 10/12/2026
- Dauch (DCH) Rebrand Keeps Undervaluation Talk Alive After A Sharp PullbackYahoo · 10/9/2026
- Barclays Maintains Equal-Weight on Dauch, Lowers Price Target to $8Benzinga · 10/9/2026
- Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market SessionBenzinga · 10/8/2026
- UBS Maintains Buy on Dauch, Lowers Price Target to $8Benzinga · 10/7/2026
- Jefferies Downgrades Dauch to Hold, Lowers Price Target to $7.1Benzinga · 9/23/2026
- Strong Sales, EV Momentum And Tariff Risks Define The Road Ahead For AutosSeekingAlpha · 9/14/2026
Insider Activity
Insider Actions →- Sherbin Joshua A · May 4, 2026 · Grant45.5K
- Kemp Terri M. · May 4, 2026 · Grant186.6K
- Sherbin Joshua A · May 4, 2026 · Grant100.7K
- Valenti Samuel III · April 30, 2026 · Grant29.8K
- Sandra E. Pierce · April 30, 2026 · Grant29.8K
- Lyons Peter David · April 30, 2026 · Grant29.8K
- Miziolek Aleksandra A · April 30, 2026 · Grant29.8K
- Grayson-Caprio Terry · April 30, 2026 · Grant29.8K
- Herbert K. Parker · April 30, 2026 · Grant29.8K
- MCCASLIN JAMES A · April 30, 2026 · Grant29.8K
- Mackenzie Smith Simon · April 30, 2026 · Grant29.8K
- Kozyra William Lawrence · April 30, 2026 · Grant29.8K
- MacAulay Fiona M · April 30, 2026 · Grant29.8K
- Walker David B. · April 30, 2026 · Grant29.8K
Institutional Ownership
March 31, 2026
- Total shares held
- 251.48M
- Total value held
- $1.46B
- Institutional holders
- 292
- Unknown37.20M
- Unknown10.16M
- Unknown9.99M
- Unknown9.24M
- Unknown9.02M
- Unknown8.47M
- Unknown7.74M
- Unknown7.02M
- Unknown6.31M
- Unknown5.78M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Dauch names new CFO, faces lower price targets from Barclays and UBS
Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.
Dauch names new CFO, faces lower price targets from Barclays and UBS. Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.